Hyperbaric oxygen therapy (HBOT) is a medical treatment in which you breathe near-100% oxygen inside a pressurized chamber. Its proven benefits are concentrated in a defined list of serious conditions—including carbon monoxide poisoning, decompression sickness, diabetic foot wounds, and delayed radiation injuries. Medicare covers HBOT for 14 specific indications under National Coverage Determination (NCD) 20.29. For most other conditions, evidence is limited, and insurance generally does not pay. A typical wound-healing course runs 30 to 40 sessions, at $200 to $450 per session at hospital-grade centers.
Quick Facts Table
Item
Information
Program
Hyperbaric Oxygen Therapy (HBOT) — a medical treatment, not a government benefit program
Agency
FDA (device regulation); CMS/Medicare (coverage); private insurers and state Medicaid programs (coverage)
Eligibility
Patients with a physician-diagnosed condition on the approved list, typically after standard therapy has failed
Income Limits
No income test. Coverage depends on diagnosis and insurance plan, not household income.
Monthly Benefit
Not a cash benefit. Insurance may pay for approved sessions; Medicare’s national estimated physician payment is about $68.80 for CPT 99183 (2026), with facility costs separate.
Application
Physician referral and order; prior authorization is common for insurance coverage
Processing Time
Prior authorization typically days to weeks; emergency HBOT (e.g., carbon monoxide poisoning) begins immediately
Renewal
Re-evaluation every 30 days is common for wound care; continued treatment requires documented measurable improvement
Hyperbaric oxygen therapy is a medical intervention in which a patient breathes near 100% oxygen inside a chamber pressurized to greater than sea-level atmospheric pressure—clinically, at least 1.4 atmospheres absolute (ATA). The increased pressure allows far more oxygen to dissolve in the blood and reach tissues that are starved of oxygen, which is why HBOT is used for wounds, crush injuries, and certain infections.
It is not a wellness treatment, and it is not the same as “mild hyperbaric” soft chambers. Soft-shell chambers that operate below 1.4 ATA are regulated differently and have received FDA clearance only for acute mountain sickness; major insurers classify mild HBOT as unproven and not medically necessary for any indication.
Who Qualifies for HBOT?
You may qualify for medically necessary HBOT if you have a condition on the accepted list and your physician documents that the criteria are met. The list below reflects conditions considered medically necessary by major payers and by the Undersea and Hyperbaric Medical Society.
Common approved indications include:
Air or gas embolism
Carbon monoxide poisoning (with or without cyanide poisoning)
Clostridial myonecrosis (gas gangrene)
Crush injury, compartment syndrome, and other acute traumatic ischemia
Decompression sickness
Diabetic lower-extremity wounds (Wagner Grade III or higher, after failed standard therapy)
Delayed radiation injuries (soft tissue and bony necrosis)
Chronic refractory osteomyelitis
Compromised skin grafts or flaps
Severe anemia when transfusion is refused, delayed, or unavailable
Central retinal artery occlusion
Idiopathic sudden sensorineural hearing loss
Intracranial abscess
Necrotizing soft tissue infections
Thermal burns (second or third degree)
Avascular necrosis (aseptic osteonecrosis)
Who does NOT qualify for insurance-covered HBOT:
Patients with conditions not on the approved list, such as autism, Alzheimer’s disease, cancer, Lyme disease, or general “wellness” or anti-aging claims. The FDA has not cleared or approved HBOT for these uses, and Harvard Health notes that claims for these conditions are unfounded.
Patients using mild, low-pressure soft chambers for any condition; these do not meet the clinical definition of HBOT and are not covered by insurance.
Patients who have not completed standard therapy for a wound or infection, unless the condition is an emergency (e.g., gas gangrene, air embolism).
Common exceptions: For diabetic foot ulcers, Medicare requires Type 1 or Type 2 diabetes, a wound classified as Wagner Grade III or higher, and failure of at least 30 days of standard wound therapy with no measurable improvement before HBOT is covered.
Coverage and Cost Limits: How “Eligibility” Works for HBOT
There is no income limit for HBOT. This is the key distinction between HBOT and programs like SNAP or Medicaid. Your ability to receive HBOT depends on medical necessity and your insurance plan, not on how much you earn.
Medicare covers HBOT under NCD 20.29 for 14 specific conditions, including acute carbon monoxide intoxication, decompression illness, gas embolism, gas gangrene, acute traumatic peripheral ischemia, crush injuries, progressive necrotizing infections, chronic refractory osteomyelitis, osteoradionecrosis, soft tissue radionecrosis, and diabetic wounds of the lower extremities. For diabetic wounds, the Wagner Grade III and 30-day failed therapy criteria apply.
Medicare’s national estimated physician payment for CPT 99183 (physician supervision of HBOT) is about $68.80** in 2026, based on the CMS Physician Fee Schedule conversion factor; facility charges are billed separately and are much higher. Medicare data cited by cost researchers show an **all-in cost per session of about $595.86 in 2022, reflecting facility and professional components.
Private Insurance
Commercial plans generally follow the same or similar medical-necessity criteria. UnitedHealthcare’s policy, for example, lists the conditions above as medically necessary and states that all other indications are unproven and not medically necessary. Prior authorization is common.
Medicaid
Medicaid is state-administered, and HBOT coverage varies by state. Some state Medicaid programs follow CMS guidelines; others are more restrictive or require prior authorization. Mississippi’s Medicaid program, for example, covers systemic HBOT in inpatient or outpatient hospital settings in accordance with UHMS standards and FDA-approved chambers. Oregon’s PacificSource Medicaid plan uses an internal clinical-criteria review process. You must check your specific state Medicaid policy.
Asset Limits and Household Requirements: Not Applicable
HBOT has no asset test and no household-composition rules. It is a medical procedure, not a means-tested benefit. The only “household” question that matters is whether the patient is the insured member or a covered dependent under the health plan.
Similarly, citizenship and immigration status are not HBOT eligibility criteria. However, the insurance program paying for HBOT—Medicare, Medicaid, or a Marketplace plan—may have its own eligibility rules for enrollment. Once enrolled, HBOT coverage depends on the medical criteria, not on immigration status.
State Differences
HBOT coverage rules are largely national for Medicare, but Medicaid is state-specific. Medicare’s NCD 20.29 applies nationwide. Private insurers typically adopt similar policies. Medicaid programs have discretion to follow CMS guidelines, be more restrictive, or cover additional indications, so a patient in one state may have access that a patient in a neighboring state does not.
Required Documents and Referral Pathway
HBOT is not something you apply for directly. You need a physician’s order and supporting medical records. Typical documentation includes:
Physician referral and order specifying the indication and treatment plan.
Medical records documenting the diagnosis, severity, and prior treatments.
For diabetic wounds: wound classification (Wagner grade) and documentation of at least 30 days of failed standard wound therapy.
Imaging or operative reports for conditions such as osteomyelitis, radiation injury, or compromised grafts.
Prior authorization forms required by the insurer, often submitted by the treating facility.
How to Get HBOT: Step-by-Step
See a physician who can diagnose the condition and determine whether it meets accepted criteria.
Obtain a referral to a hospital-based or freestanding hyperbaric medicine program. Wound care centers are common entry points for diabetic and radiation injuries.
The program submits prior authorization to your insurance plan, including the diagnosis, wound grade, and prior treatment history.
Insurance reviews medical necessity against NCD 20.29 or its own policy.
Treatment begins once authorized. Emergency indications (carbon monoxide poisoning, gas embolism, decompression sickness) are treated immediately without waiting for routine authorization.
Online Application: Not Applicable
There is no online application for HBOT. Unlike SNAP or Medicaid, HBOT is arranged through a physician and a treating facility. You cannot “apply” for HBOT on a government website. The closest equivalent is your insurer’s prior authorization portal, which is used by the provider—not the patient—to request approval.
Processing Time and Scheduling
Routine prior authorization typically takes days to weeks, depending on the insurer and the completeness of documentation. Emergency HBOT starts immediately. For wound care, treatment is usually scheduled once daily, five days per week, with each session lasting roughly 90 to 120 minutes plus pressurization and depressurization time.
Payment Schedule and Cost
HBOT is billed per session, not as a monthly benefit. Costs vary widely by setting and pressure.
Setting
Typical Cost Per Session
Typical Pressure
Insurance Coverage
Hospital-grade hard-shell chamber
$400–$700 cash; insurance may be billed
2.0–3.0 ATA
Yes, for approved indications
Freestanding clinical hard-shell
$200–$450
2.0–3.0 ATA
Yes, for approved indications
Wellness soft-shell (mild HBOT)
$75–$150
1.3–1.5 ATA
No — considered unproven
Home soft chamber rental
$600–$2,200/month
1.3–1.5 ATA
No
A full wound-healing course of 30 to 40 sessions can total $6,000 to $28,000 or more at hospital-grade rates, depending on the facility and insurance negotiated rates. Emergency treatment for carbon monoxide poisoning may require only 1 to 3 sessions; chronic wounds often require 20 to 40 or more.
Renewal Process: Re-evaluation, Not “Renewal”
HBOT does not have a renewal application. Instead, continued treatment requires documented improvement. For wound care, insurers commonly require re-evaluation every 30 days, and treatment may be stopped if there are no measurable signs of healing. Your physician must justify additional sessions with wound measurements, imaging, or clinical notes.
The diagnosis is not on the approved list (e.g., autism, Lyme disease, general wellness).
The wound does not meet severity criteria (e.g., diabetic ulcer below Wagner Grade III).
Standard therapy has not been tried for the required duration (30 days for diabetic wounds).
Mild HBOT was used—soft chambers below 1.4 ATA do not meet the clinical definition and are not covered.
Documentation is incomplete—missing wound measurements, prior treatment records, or physician orders.
HBOT is used as primary therapy when the payer requires it to be adjunctive to surgery or antibiotics.
Out-of-network facility without prior approval.
Appeals Process
You can appeal a denial, but the deadline and process depend on your insurer. For Medicare, you have the standard Medicare appeal rights outlined in your denial notice, with deadlines that may be as short as 60 days for a redetermination. For private plans, the appeal deadline is typically 180 days for ERISA plans. The appeal should include:
A copy of the denial letter.
A letter from your physician explaining why HBOT is medically necessary.
Medical records, wound measurements, and documentation of failed standard therapy.
Supporting clinical guidelines or peer-reviewed evidence.
Expedited appeals are available for urgent cases. If you are a Medicare beneficiary, you can request a fast appeal if your physician certifies that waiting could seriously jeopardize your health.
Common Mistakes
Paying out of pocket for mild HBOT without understanding that it is not the same as clinical HBOT and is not covered by insurance.
Assuming insurance will cover off-label use for conditions like autism, Alzheimer’s, or long COVID; most plans will not.
Skipping standard wound therapy to go straight to HBOT; insurers require documented failure of conservative care first.
Using a facility that does not provide proper documentation for prior authorization.
Missing the appeal deadline after a denial.
Not checking state Medicaid rules if you are covered by Medicaid; coverage varies significantly.
Recent Changes and Current Evidence (2025–2026)
The evidence base for HBOT continues to grow, but it remains concentrated in the approved indications. A 2026 meta-analysis in Diabetes Care found that HBOT significantly improved ulcer healing in diabetic foot ulcers compared with controls (risk ratio 1.97) and reduced major amputations, supporting the existing Medicare criteria. A 2026 systematic review on chronic pain found consistent within-group improvements in fibromyalgia but limited evidence in complex regional pain syndrome and trigeminal neuralgia; a trial in radiation-induced brachial plexopathy showed no meaningful improvement. A 2026 review on stroke concluded that HBOT was not associated with significant recovery in subacute-to-chronic stroke, though post hoc analyses suggested possible benefit with 15–24 sessions.
For PTSD, long COVID, and other off-label conditions, evidence remains preliminary. A 2026 PTSD trial found symptomatic improvement, but optimal dosing is unclear. Harvard Health continues to list Alzheimer’s disease, autism, cancer, and Lyme disease as conditions without scientific backing for HBOT.
Regulatory focus on safety has increased. In 2026, the FDA updated guidance emphasizing the safe use of hyperbaric chambers and compliance with manufacturer instructions; emergency physicians and the UHMS have raised concerns about poorly regulated mild hyperbaric chambers.
Common Questions (12 FAQs)
1. What conditions does hyperbaric oxygen therapy actually treat? HBOT is proven and covered for a defined list that includes carbon monoxide poisoning, decompression sickness, gas embolism, gas gangrene, crush injuries, diabetic foot ulcers (Wagner Grade III+), delayed radiation injuries, chronic refractory osteomyelitis, compromised skin grafts, and a small number of other serious conditions. It is not a general wellness treatment.
2. Does Medicare cover hyperbaric oxygen therapy? Yes, for 14 specific conditions under NCD 20.29. For diabetic lower-extremity wounds, Medicare requires Wagner Grade III or higher and at least 30 days of failed standard wound therapy.
3. How much does HBOT cost per session? Hospital-grade hard-shell HBOT typically costs $400–$700 per session; freestanding clinics charge $200–$450. Mild soft-shell “wellness” sessions cost $75–$150 but are not covered by insurance.
4. How many sessions will I need? It depends on the condition. Emergency carbon monoxide poisoning may need 1–3 sessions. Chronic wounds typically require 20–40 sessions, often five days per week. Most treatment plans involve at least 20 sessions.
5. Is HBOT covered for autism, Alzheimer’s, or Lyme disease? No. The FDA has not cleared or approved HBOT for these conditions, and major insurers classify them as unproven. You would pay out of pocket, and Harvard Health notes the claims are not supported by scientific evidence.
6. What is the difference between clinical HBOT and mild HBOT? Clinical HBOT uses near-100% oxygen at 1.4 ATA or higher. Mild HBOT uses soft chambers at 1.3–1.5 ATA with ambient air, and it is FDA-cleared only for acute mountain sickness. Insurers consider mild HBOT unproven for all other uses.
7. Does Medicaid cover HBOT? It varies by state. Some state Medicaid programs follow Medicare’s criteria; others are more restrictive or require prior authorization. Check your state Medicaid policy.
8. Is HBOT safe? Serious complications are uncommon but real. Risks include barotrauma to the ear or lung, oxygen toxicity (seizures), temporary nearsightedness, and, rarely, fire. Fire is the most common fatal complication, though deaths are rare relative to millions of treatments.
9. Can I get HBOT without insurance? Yes. You can pay cash at a hospital or freestanding clinic, but costs are significant—often $200–$700 per session for clinical HBOT. Mild soft-shell sessions are cheaper but are not the same treatment.
10. Why was my HBOT claim denied? Common reasons include an unapproved diagnosis, a wound that does not meet severity criteria, missing documentation of failed standard therapy, use of mild HBOT, or incomplete prior authorization.
11. Does the VA cover HBOT? The VA may provide HBOT when it is medically necessary for an approved condition and delivered through VA or VA-authorized care. Eligibility depends on VA health care enrollment and clinical criteria. Ask your VA provider for a referral.
12. Is HBOT FDA-approved? The FDA regulates hyperbaric chambers as medical devices and has cleared them for specific uses. The agency does not “approve” medical treatments in the way it approves drugs, but it has cleared HBOT for the recognized indications and warned against unproven claims.
Key Takeaways
HBOT is a medical treatment, not a government benefit. There is no income test or asset test.
Medicare covers HBOT for 14 conditions under NCD 20.29; diabetic wounds require Wagner Grade III+ and 30 days of failed standard therapy.
The strongest evidence is for carbon monoxide poisoning, decompression sickness, gas embolism, diabetic foot ulcers, and delayed radiation injuries.
Mild soft-shell HBOT is not clinical HBOT and is considered unproven by major insurers.
Typical wound-healing courses run 20–40 sessions; emergency treatment may need only 1–3.
Costs range from $200 to $700 per session at clinical facilities; a full course can exceed $20,000.
If you are seeking financial help with medical care or living expenses, these programs may be relevant. None of them pay for HBOT directly, but they may help with overall costs.
Medicare: Federal health insurance for people 65+ and some younger people with disabilities. Covers HBOT for approved indications.
Medicaid: State-federal health coverage for low-income people. HBOT coverage varies by state.
VA Health Care: Health benefits for eligible veterans. May cover HBOT when medically necessary.
CHIP (Children’s Health Insurance Program): Health coverage for children in families with modest incomes. HBOT coverage would follow the state plan’s medical policy.
Social Security Disability Insurance (SSDI): Cash benefits for people who cannot work due to disability; provides Medicare after a waiting period.
Supplemental Security Income (SSI): Cash assistance for aged, blind, or disabled people with limited income and resources; often linked to Medicaid.
Health Insurance Marketplace: Subsidized private plans under the Affordable Care Act; HBOT coverage depends on the plan’s medical policy.
Medicare Savings Programs: Help with Medicare premiums and cost-sharing for low-income beneficiaries.
LIHEAP:Utility assistance for low-income households, freeing up income for medical costs.
SNAP: Food assistance, which can help households redirect limited resources toward medical care.
